Nifty
Sensex
:
:
11600.20
39090.03
326.00 (2.89%)
1075.41 (2.83%)

Pharmaceuticals & Drugs

Rating :
65/99  (View)

BSE: 532482 | NSE: GRANULES

107.05
-0.20 (-0.19%)
23-Sep-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  108.00
  •  109.75
  •  105.90
  •  107.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  596111
  •  638.14
  •  120.40
  •  79.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,719.18
  • 10.15
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,621.32
  • 0.94%
  • 1.73

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.90%
  • 8.34%
  • 29.27%
  • FII
  • DII
  • Others
  • 3.11%
  • 0.00%
  • 16.38%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.33
  • 12.01
  • 17.34

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.11
  • 12.98
  • 5.14

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.98
  • 15.60
  • 10.32

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.93
  • 18.70
  • 17.35

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.57
  • 3.37
  • 2.45

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.71
  • 10.73
  • 10.32

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
595.27
453.24
31.34%
613.32
503.82
21.73%
631.78
410.73
53.82%
580.87
392.56
47.97%
Expenses
476.65
380.64
25.22%
515.71
460.19
12.06%
518.48
336.70
53.99%
480.34
315.65
52.17%
EBITDA
118.62
72.60
63.39%
97.61
43.63
123.72%
113.30
74.03
53.05%
100.53
76.91
30.71%
EBIDTM
19.93%
16.02%
15.91%
8.66%
17.93%
18.02%
17.31%
19.59%
Other Income
1.86
14.74
-87.38%
1.88
9.67
-80.56%
5.88
0.86
583.72%
4.18
6.83
-38.80%
Interest
6.87
6.54
5.05%
6.85
6.21
10.31%
7.47
8.23
-9.23%
7.60
10.41
-26.99%
Depreciation
28.67
24.53
16.88%
27.42
20.41
34.35%
27.01
19.60
37.81%
26.53
18.59
42.71%
PBT
84.94
56.27
50.95%
65.22
26.69
144.36%
84.69
47.06
79.96%
70.59
54.74
28.96%
Tax
27.19
19.11
42.28%
20.18
9.50
112.42%
26.46
16.90
56.57%
23.35
19.26
21.24%
PAT
57.75
37.16
55.41%
45.04
17.19
162.01%
58.23
30.16
93.07%
47.23
35.48
33.12%
PATM
9.70%
8.20%
7.34%
3.41%
9.22%
7.34%
8.13%
9.04%
EPS
3.27
2.04
60.29%
2.52
0.81
211.11%
2.37
1.38
71.74%
2.37
1.59
49.06%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
2,421.24
2,279.20
1,684.62
1,410.57
1,357.18
1,292.92
1,095.86
764.37
653.97
475.18
461.09
Net Sales Growth
37.54%
35.29%
19.43%
3.93%
4.97%
17.98%
43.37%
16.88%
37.63%
3.06%
 
Cost Of Goods Sold
1,303.88
1,255.56
896.32
679.63
725.03
746.95
645.25
466.92
414.36
295.55
275.07
Gross Profit
1,117.36
1,023.64
788.30
730.93
632.15
545.97
450.61
297.45
239.60
179.63
186.02
GP Margin
46.15%
44.91%
46.79%
51.82%
46.58%
42.23%
41.12%
38.91%
36.64%
37.80%
40.34%
Total Expenditure
1,991.18
1,895.16
1,406.20
1,111.73
1,081.29
1,084.31
937.57
679.35
574.68
418.92
399.65
Power & Fuel Cost
-
57.67
48.22
38.67
34.97
45.73
36.70
37.71
26.28
23.07
18.61
% Of Sales
-
2.53%
2.86%
2.74%
2.58%
3.54%
3.35%
4.93%
4.02%
4.86%
4.04%
Employee Cost
-
209.82
165.21
140.19
117.57
106.96
85.84
59.71
45.46
33.38
27.78
% Of Sales
-
9.21%
9.81%
9.94%
8.66%
8.27%
7.83%
7.81%
6.95%
7.02%
6.02%
Manufacturing Exp.
-
157.62
123.40
88.60
66.97
50.89
38.68
24.34
18.90
14.71
30.79
% Of Sales
-
6.92%
7.33%
6.28%
4.93%
3.94%
3.53%
3.18%
2.89%
3.10%
6.68%
General & Admin Exp.
-
99.96
80.48
67.65
60.38
59.84
44.42
26.96
21.31
16.52
18.01
% Of Sales
-
4.39%
4.78%
4.80%
4.45%
4.63%
4.05%
3.53%
3.26%
3.48%
3.91%
Selling & Distn. Exp.
-
91.84
83.08
81.37
67.75
71.70
85.04
61.70
47.62
32.32
28.47
% Of Sales
-
4.03%
4.93%
5.77%
4.99%
5.55%
7.76%
8.07%
7.28%
6.80%
6.17%
Miscellaneous Exp.
-
22.69
9.49
15.61
8.62
2.24
1.64
2.01
0.74
3.36
28.47
% Of Sales
-
1.00%
0.56%
1.11%
0.64%
0.17%
0.15%
0.26%
0.11%
0.71%
0.20%
EBITDA
430.06
384.04
278.42
298.84
275.89
208.61
158.29
85.02
79.29
56.26
61.44
EBITDA Margin
17.76%
16.85%
16.53%
21.19%
20.33%
16.13%
14.44%
11.12%
12.12%
11.84%
13.32%
Other Income
13.80
26.68
10.84
9.93
5.62
4.34
4.31
2.06
1.38
0.80
12.28
Interest
28.79
28.46
33.06
32.26
37.07
32.35
20.43
17.67
16.99
11.99
17.55
Depreciation
109.63
105.48
76.20
71.51
58.40
52.65
29.81
23.08
20.70
18.31
18.57
PBT
305.44
276.78
180.00
204.99
186.03
127.96
112.36
46.32
42.98
26.76
37.60
Tax
97.18
89.11
63.40
65.20
61.15
37.05
37.13
13.76
13.02
5.86
7.22
Tax Rate
31.82%
32.20%
35.22%
31.81%
32.87%
28.95%
33.05%
29.71%
30.29%
21.90%
19.20%
PAT
208.25
187.67
116.60
139.79
124.89
90.91
75.23
32.57
29.95
20.90
30.37
PAT before Minority Interest
208.25
187.67
116.60
139.79
124.89
90.91
75.23
32.57
29.95
20.90
30.37
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
8.60%
8.23%
6.92%
9.91%
9.20%
7.03%
6.86%
4.26%
4.58%
4.40%
6.59%
PAT Growth
73.56%
60.95%
-16.59%
11.93%
37.38%
20.84%
130.98%
8.75%
43.30%
-31.18%
 
Unadjusted EPS
10.53
9.30
5.49
7.52
5.95
4.46
3.72
16.21
14.93
10.42
15.14

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
1,529.47
1,304.18
903.60
661.60
431.16
355.96
274.85
245.09
219.78
202.38
Share Capital
25.42
25.38
22.87
21.67
20.43
20.28
20.13
20.06
20.06
21.74
Total Reserves
1,493.09
1,273.38
878.28
611.13
410.74
335.43
254.41
225.03
199.72
180.64
Non-Current Liabilities
552.63
488.19
187.99
246.62
356.52
343.51
202.00
112.60
58.88
163.74
Secured Loans
478.78
433.13
123.90
183.66
302.59
295.86
174.85
87.30
37.08
135.85
Unsecured Loans
0.00
0.00
0.34
0.55
0.62
13.38
0.65
0.75
0.75
10.85
Long Term Provisions
12.58
7.70
7.25
5.58
4.03
3.97
2.04
1.53
1.19
0.00
Current Liabilities
896.48
844.57
787.13
654.75
415.03
292.54
205.78
213.63
157.11
49.26
Trade Payables
323.48
252.18
215.98
181.10
187.63
135.54
91.84
75.52
51.81
37.56
Other Current Liabilities
113.60
58.67
93.43
79.21
88.98
47.78
23.77
31.39
18.65
8.77
Short Term Borrowings
454.21
525.10
473.83
392.85
124.97
100.91
85.46
102.06
83.15
0.00
Short Term Provisions
5.20
8.62
3.90
1.58
13.45
8.30
4.71
4.66
3.50
2.93
Total Liabilities
2,978.58
2,636.94
1,878.72
1,562.97
1,202.71
992.01
682.63
571.32
435.77
415.38
Net Block
944.25
776.73
644.34
559.94
616.55
482.47
263.46
250.42
238.62
236.77
Gross Block
1,472.94
1,199.63
983.66
822.98
843.76
653.90
387.41
354.50
322.61
302.76
Accumulated Depreciation
528.69
422.90
339.32
263.05
227.21
171.43
123.95
104.07
83.99
65.99
Non Current Assets
1,696.34
1,483.71
1,050.55
744.97
699.69
611.55
388.87
310.52
256.75
239.52
Capital Work in Progress
495.95
514.52
267.43
76.56
62.03
124.56
108.80
29.30
6.85
2.45
Non Current Investment
210.42
156.56
108.23
70.11
0.19
0.19
0.19
0.19
0.30
0.30
Long Term Loans & Adv.
45.72
35.91
30.56
38.37
20.76
4.33
16.42
30.50
10.71
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.15
0.00
0.00
0.12
0.27
0.00
Current Assets
1,282.24
1,153.23
828.16
818.00
500.36
376.92
288.88
260.26
179.02
174.29
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
9.46
0.00
0.00
0.00
Inventories
384.21
279.95
269.18
253.72
224.52
174.16
136.48
109.91
75.13
68.63
Sundry Debtors
673.54
617.08
417.70
375.35
136.91
110.91
71.02
95.01
71.61
65.85
Cash & Bank
89.04
115.64
49.80
130.29
65.31
41.75
41.71
31.98
11.99
13.47
Other Current Assets
135.45
48.79
39.83
9.97
73.63
50.10
30.21
23.36
20.29
26.32
Short Term Loans & Adv.
98.46
91.78
51.66
48.68
2.05
28.76
16.93
13.18
12.28
22.70
Net Current Assets
385.76
308.65
41.03
163.25
85.33
84.38
83.09
46.63
21.91
125.03
Total Assets
2,978.58
2,636.94
1,878.71
1,562.97
1,202.72
992.01
682.64
571.31
435.77
415.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
262.24
-0.65
188.24
151.43
150.28
107.95
91.18
25.60
48.56
59.73
PBT
276.78
180.00
204.99
186.03
127.96
112.36
46.32
42.98
26.76
37.60
Adjustment
149.85
107.45
95.14
92.63
85.37
50.39
41.46
37.74
33.11
24.93
Changes in Working Capital
-75.94
-230.03
-52.37
-79.70
-31.34
-31.03
14.60
-43.61
-5.70
3.46
Cash after chg. in Working capital
350.69
57.42
247.77
198.97
182.00
131.73
102.39
37.11
54.16
65.99
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-88.45
-58.07
-59.53
-47.54
-31.72
-23.78
-11.20
-11.51
-5.60
-6.26
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-269.82
-462.31
-326.09
-161.65
-145.55
-254.63
-127.79
-54.47
-25.09
-13.36
Net Fixed Assets
-176.36
-282.01
-249.86
-75.62
-231.53
-64.60
-89.18
-54.67
-23.22
-10.88
Net Investments
-431.34
-0.01
13.84
-16.48
72.98
-94.69
-17.96
-10.20
0.00
-0.93
Others
337.88
-180.29
-90.07
-69.55
13.00
-95.34
-20.65
10.40
-1.87
-1.55
Cash from Financing Activity
-17.43
528.62
55.87
85.67
18.83
146.72
46.33
48.86
-24.96
-45.73
Net Cash Inflow / Outflow
-25.01
65.66
-81.98
75.44
23.56
0.04
9.72
19.99
-1.49
0.64
Opening Cash & Equivalents
108.03
42.37
124.35
54.85
41.75
41.71
31.98
11.99
13.47
12.84
Closing Cash & Equivalent
83.02
108.03
42.37
130.29
65.31
41.75
41.71
31.98
11.99
13.47

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
59.73
51.17
39.40
29.20
20.98
17.36
13.40
12.19
10.96
9.93
ROA
6.64%
5.16%
8.12%
9.03%
8.31%
8.98%
5.19%
5.95%
4.91%
7.41%
ROE
13.32%
10.60%
18.23%
23.53%
23.29%
24.20%
12.67%
12.90%
9.98%
16.40%
ROCE
12.71%
11.09%
16.57%
20.16%
18.75%
19.90%
12.95%
14.89%
11.00%
15.67%
Fixed Asset Turnover
1.71
1.55
1.59
1.66
1.77
2.14
2.11
1.96
1.54
1.58
Receivable days
104.24
111.62
100.84
67.60
33.47
29.73
38.66
45.82
52.00
50.21
Inventory Days
53.18
59.23
66.49
63.11
54.79
50.77
57.37
50.89
54.38
49.89
Payable days
54.96
59.44
64.87
59.99
53.57
43.67
44.19
40.05
38.81
29.80
Cash Conversion Cycle
102.46
111.41
102.46
70.72
34.69
36.83
51.84
56.66
67.57
70.30
Total Debt/Equity
0.65
0.75
0.73
1.01
1.14
1.25
1.00
0.83
0.63
0.73
Interest Cover
10.72
6.44
7.36
6.02
4.96
6.50
3.62
3.53
3.23
3.14

News Update


  • Granules India enteres into agreement with S.A. Ajinomoto OmniChem N.V
    16th Sep 2019, 10:05 AM

    Conclusion of this transaction is subject to fulfillment of certain closing conditions as well as customary government approvals

    Read More
  • USFDA issues EIR for Granules India’s Bonthapally facility in Hyderabad
    13th Sep 2019, 10:27 AM

    This facility was inspected by USFDA in July 2019

    Read More
  • Granules India to divest entire stake held in joint venture
    29th Aug 2019, 12:55 PM

    The Board of Directors of the company at their meeting held on August 29, 2019, approved the same

    Read More
  • USFDA completes inspection at facility of Granules India’s arm
    22nd Aug 2019, 11:56 AM

    This is a pre-approval inspection for seven products filed from this facility

    Read More
  • Granules India’s arm receives USFDA’s approval for Amphetamine Sulfate Tablets
    6th Aug 2019, 09:56 AM

    Amphetamine Sulfate tablets is a central nervous system stimulant used to treat sleep disorder

    Read More
  • Granules India reports 61% rise in Q1 consolidated net profit
    30th Jul 2019, 14:05 PM

    Total income of the company increased by 27.60% at Rs 597.13 crore for Q1FY20

    Read More
  • Granules India - Quarterly Results
    30th Jul 2019, 12:18 PM

    Read More
  • USFDA completes inspection at Granules India's Hyderabad facility
    29th Jul 2019, 09:12 AM

    The inspection concluded with one 483 observation which is procedural in nature

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.